Lobbying Filing Details

Total Spending

$60,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
a9383920-bde3-4465-8e78-108141ef613d
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 3:02 PM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Brian Pomper
Registrant
AKIN GUMP STRAUSS HAUER & FELD

Law firm

WASHINGTON, District of Columbia
Client
KYVERNA THERAPEUTICS, INC.

Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.

California, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027.

Lobbyists (2)
  • ANNA ABRAM
  • KANDIS MCCLURE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.